LPTX logo

Leap Therapeutics (LPTX) Accounts Receivable

Annual Accounts Receivable

N/A

31 December 2023

LPTX Accounts Receivable Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Accounts Receivable

N/A

30 September 2024

LPTX Quarterly Accounts Receivable Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

LPTX Accounts Receivable Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year--
3 y3 years--
5 y5 years--

LPTX Accounts Receivable High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years
5 y5 years
alltimeall time

Leap Therapeutics Accounts Receivable History

DateAnnualQuarterly
Sept 2015
-
$504.00 K(+46.5%)
June 2015
-
$344.00 K(-28.3%)
Mar 2015
-
$480.00 K(-59.1%)
Sept 2014
-
$1.18 M(-54.6%)
DateAnnualQuarterly
June 2014
-
$2.59 M(+123.9%)
Mar 2014
-
$1.16 M(+423.5%)
Dec 2013
-
$221.00 K
Dec 2012
$205.00 K
-

FAQ

  • What is the all time high annual accounts receivable for Leap Therapeutics?
  • What is the all time high quarterly accounts receivable for Leap Therapeutics?

What is the all time high annual accounts receivable for Leap Therapeutics?

Leap Therapeutics all-time high annual accounts receivable is $205.00 K

What is the all time high quarterly accounts receivable for Leap Therapeutics?

Leap Therapeutics all-time high quarterly accounts receivable is $2.59 M